Does DAPAGLIFLOZIN Cause Peripheral arterial occlusive disease? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Peripheral arterial occlusive disease have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.2% of all adverse event reports for DAPAGLIFLOZIN.
43
Reports of Peripheral arterial occlusive disease with DAPAGLIFLOZIN
0.2%
of all DAPAGLIFLOZIN reports
3
Deaths
27
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From DAPAGLIFLOZIN?
Of the 43 reports, 3 (7.0%) resulted in death, 27 (62.8%) required hospitalization, and 14 (32.6%) were considered life-threatening.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
Which DAPAGLIFLOZIN Alternatives Have Lower Peripheral arterial occlusive disease Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN